Infertility Services Market in US 2017-2021


#1027795

80pages

Technavio

$ 3500

In Stock

About Infertility Services

Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy.

Technavios analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the infertility services market in US for 2017-2021. To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services.

Technavio's report, Infertility Services Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife

Other prominent vendors
AbbVie
Apricus Biosciences
AstraZeneca
Auxogyn
Eli Lilly
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
Virtus Health
Xytex Cryo International

Market driver
Rising success rate of infertility treatments.
For a full, detailed list, view our report

Market challenge
Limited reimbursements and lack of strict regulatory oversight.
For a full, detailed list, view our report

Market trend
Upsurge in mergers and acquisitions.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents

PART 01: Executive summary

PART 02: Scope of the report


Market overview
Vendor analysis
Top-vendor offerings


PART 03: Market research methodology


Research methodology
Economic indicators


PART 04: Introduction


Key market highlights


PART 05: Market landscape


Market overview
Market size and forecast
Five forces analysis


PART 06: Market segmentation by underlying cause

PART 07: Market segmentation by services


Market overview
ART services market in US
Infertility drugs services market in US


PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape


Competitive scenario
Other prominent vendors


PART 14: Key Vendor Analysis


CARE Fertility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife


PART 15: Appendix


List of abbreviations


PART 16: Explore Technavio
List of Exhibits

Exhibit 01: US infertility services market segmentation: Overview

Exhibit 02: Product offerings

Exhibit 03: Assessment of regulatory bodies

Exhibit 04: Snapshot: Infertility services market in US

Exhibit 05: US fertility chart 2015

Exhibit 06: Stages of infertility treatment

Exhibit 07: Infertility services market in the US 2016-2021 ($ billions)

Exhibit 08: Side effects and success rates of infertility services in US

Exhibit 09: Impact of various factors on infertility services in US

Exhibit 10: Recommendations to vendors

Exhibit 11: Five forces analysis

Exhibit 12: Infertility services market in US by underlying cause

Exhibit 13: Diagnosis of infertility

Exhibit 14: Market segmentation by services 2016-2021(in %)

Exhibit 15: Snapshot: US fertility services market by product

Exhibit 16: Categories of ART services 2016

Exhibit 17: IVF overview

Exhibit 18: ART services market in US 2016-2021 ($ billions)

Exhibit 19: Comparison of fresh and frozen ART cycle

Exhibit 20: Infertility drugs services market in US 2016-2021($ billions)

Exhibit 21: Success rate of IVF procedures

Exhibit 22: ART procedures in US (in thousands)

Exhibit 23: Obesity prevalence in the US (2015)

Exhibit 24: Infertility rates by age

Exhibit 25: US birth rates by women

Exhibit 26: Impact of drivers

Exhibit 27: Cost breakdown of IVF by various stages in US

Exhibit 28: Impact of drivers and challenges

Exhibit 29: Notable M&A activity

Exhibit 30: Same sex married couples in US

Exhibit 31: CARE Fertility: Profile

Exhibit 32: CARE Fertility: Strength analysis

Exhibit 33: CARE Fertility: Strategy assessment

Exhibit 34: CARE Fertility: Opportunity assessment

Exhibit 35: CooperSurgical: Profile

Exhibit 36: CooperSurgical: Strength analysis

Exhibit 37: CooperSurgical: Growth strategy assessment

Exhibit 38: CooperSurgical: Opportunity assessment

Exhibit 39: Ferring Pharmaceuticals: Profile

Exhibit 40: Ferring Pharmaceuticals: Strength analysis

Exhibit 41: Ferring Pharmaceuticals: Strategy assessment

Exhibit 42: Ferring Pharmaceuticals: Opportunity assessment

Exhibit 43: Monash IVF: Profile

Exhibit 44: Monash IVF: Strength analysis

Exhibit 45: Monash IVF: Strategy assessment

Exhibit 46: Monash IVF: Opportunity assessment

Exhibit 47: Merck: Profile

Exhibit 48: Merck: Strength analysis

Exhibit 49: Merck: Strategy assessment

Exhibit 50: Merck: Opportunity assessment

Exhibit 51: Vitrolife: Profile

Exhibit 52: Vitrolife: Strength analysis

Exhibit 53: Vitrolife: Strategy assessment

Exhibit 54: Vitrolife: Opportunity assessment